CDEK
← All organizations

Alvogen

For profitContributed to NMEWebsite ↗

Also known as: ALMATICA | ALVOGEN | ALVOGEN INC | Alvogen Korea | ALVOGEN MALTA | ALVOGEN PINE BROOK | Alvogen Pine Brook LLC

Phase 1Phase 2Phase 3Phase 4

Highest phase reached

Phase 4

First clinical trial

Feb 1, 2011

First marketed drug

Jun 1, 2008

First NDA

Jun 29, 2022

Last known activity

Feb 27, 2026

Timeline

1980s

  1. Dec 23, 1982

    econazole— NDA Organization

2000s

  1. Jun 1, 2008

    Alvogen— Founded

2010s

  1. Dec 31, 2012

    LaborMed Pharma S.A.— Acquired

  2. Jan 3, 2014

    Lotus Pharmaceutical— Acquired

  3. Aug 6, 2014

    Dream Pharma Corp— Acquired

  4. Jun 1, 2015

    KunWha Pharmaceutical Co., Ltd.— Acquired

  5. Mar 7, 2016

    County Line— Acquired

  6. Aug 15, 2017

    Omega Bittner— Acquired

2020s

  1. Apr 23, 2021

    naltrexone— Marketing Organization

  2. Aug 27, 2021

    lorazepam— NDA Secondary Org

Drugs by trial phase (22 distinct, 28 trials)

Phase 1 (4 own, 0 via acquisition)

Indications

Approved for

Studied for

Marketed drugs (72)

Subsidiaries (6 direct, 6 total across the full acquisition tree)

Recent trials (24)

Details

Founded
Pine Brook, NJ, US Jun 1, 2008
First NDA
Jun 29, 2022
Last known activity
Feb 27, 2026